0001477932-24-003484.txt : 20240604
0001477932-24-003484.hdr.sgml : 20240604
20240604160605
ACCESSION NUMBER: 0001477932-24-003484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240601
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Micallef Jacob Vincent
CENTRAL INDEX KEY: 0001651671
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 241017957
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0508
4
2024-06-01-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001651671
Micallef Jacob Vincent
1489 WEST WARM SPRINGS ROAD
SUITE 110
HENDERSON
NV
89014
false
true
false
false
Chief Scientific Officer
false
Common Stock
2024-06-01-05:00
4
A
false
40709
0
A
299224
D
Common Stock
55000
I
By Spouse
Common Stock
38113
I
By Borlaug Limited
On June 1, 2024, the reporting person was awarded 40,709 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 13,570 units, 13,570 units, and 13,569 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.
/s/ Jacob Vincent Micallef
2024-06-04-05:00